10x Genomics (TXG) Deferred Taxes (2018 - 2019)
10x Genomics (TXG) reported Deferred Taxes of -$111000.0 for Q4 2019, down 103.88% on a YoY basis from $2.9 million in Q4 2018, and down 109.64% sequentially from $1.2 million in Q3 2019.
10x Genomics (TXG) Deferred Taxes (2018 - 2019) Analysis & Trends
10x Genomics (TXG) has 2 years of Deferred Taxes data on file, last reported at -$111000.0 in Q4 2019.
- For the quarter ending Q4 2019, Deferred Taxes fell 103.88% year-over-year to -$111000.0; the trailing twelve-month figure through Dec 2020 stood at $1.0 million (down 91.83% YoY), and the FY2019 full-year result was $12.7 million, up 282.51% from the prior year.
- Deferred Taxes retreated to -$111000.0 in Q4 2019, from $1.2 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $7.3 million in Q1 2019 to a low of -$111000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 14.34 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | -7.19 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 10.11 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -55.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | -2.10 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 32.14 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 2.53 Mn |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | 4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -111,000.00 |
| Sep 30, 2019 | 1.15 Mn |
| Jun 30, 2019 | 4.41 Mn |
| Mar 31, 2019 | 7.28 Mn |
| Dec 31, 2018 | 2.86 Mn |